Other OTC Pharmaceuticals (Pharmacies) - Western Africa

  • Western Africa
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$70.36m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.06%, resulting in a market volume of US$77.90m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.17 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Western Africa has been experiencing significant growth in recent years. This can be attributed to a variety of factors, including changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Other OTC Pharmaceuticals (Pharmacies) market in Western Africa have shifted towards a greater demand for accessible and affordable healthcare products. This is due to the increasing awareness about the importance of self-care and the desire for convenience. Customers are seeking over-the-counter medications and healthcare products that they can easily purchase without a prescription and use at their own discretion. This preference for self-care has led to a rise in the demand for a wide range of OTC pharmaceuticals, including pain relievers, cold and flu medications, digestive health products, and vitamins and supplements. One of the key trends in the market is the growing popularity of traditional medicine. Western Africa has a rich tradition of herbal medicine, and many consumers in the region prefer natural remedies over synthetic drugs. This trend has led to an increase in the availability and demand for herbal and traditional OTC pharmaceuticals in pharmacies. Additionally, there has been a rise in the use of mobile technology for healthcare purposes, with more consumers using mobile apps and online platforms to access information about OTC pharmaceuticals and make purchases. Local special circumstances in Western Africa also contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market. The region has a growing population and an increasing middle class, which has led to a higher demand for healthcare products and services. Additionally, there is a lack of access to healthcare facilities in many parts of Western Africa, making pharmacies a crucial source of healthcare products for the local population. Pharmacies often serve as the first point of contact for individuals seeking healthcare advice and treatment, making them an important player in the healthcare ecosystem. Underlying macroeconomic factors, such as economic growth and urbanization, also play a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market in Western Africa. As economies in the region continue to grow, disposable incomes are increasing, allowing more individuals to afford healthcare products. Furthermore, urbanization is leading to a higher concentration of population in cities, creating a larger customer base for pharmacies. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Western Africa is experiencing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for accessible and affordable healthcare products, the popularity of traditional medicine, the use of mobile technology, a growing population and middle class, and economic growth and urbanization are all contributing to the development of the market in the region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)